Drug Shortage Report for CIPRALEX -20MG

Last updated on 2020-01-22 History
Report ID 103600
Drug Identification Number 02263254
Brand name CIPRALEX -20MG
Common or Proper name ESCITALOPRAM
Company Name LUNDBECK CANADA INC
Market Status MARKETED
Active Ingredient(s) ESCITALOPRAM
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-13
Estimated end date
Actual end date 2020-01-21
Shortage status Resolved
Updated date 2020-01-22
Company comments minor graphic error
Health Canada comments
Tier 3 Status No
Contact Address 2600 ALFRED-NOBEL, SUITE 400
ST-LAURENT, QUEBEC
CANADA H4S 0A9
Company contact information 514-844-8515 / Canada@Lundbeck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-01-22 English Compare
v6 2020-01-21 French Compare
v5 2020-01-21 English Compare
v4 2020-01-21 English Compare
v3 2020-01-17 French Compare
v2 2020-01-17 English Compare
v1 2020-01-17 English Compare

Showing 1 to 7 of 7